Article ID Journal Published Year Pages File Type
1919067 Maturitas 2006 8 Pages PDF
Abstract

ObjectivesProstate cancers and many thereof derived cell lines, as the LNCaP cells, grow androgen-dependent. In vivo testosterone is locally converted by 5α-reductase to 5α-dihydrotestosterone (5α-DHT) which is the major androgenic principle in prostates and seminal vesicles. The occurrence of prostate cancer and growth of LNCaP cells can be effectively inhibited by finasteride, a synthetic 5α-reductase inhibitor and by a black cohosh (Cimicifuga racemosa, CR) extract. In the present contribution we tested whether the aqueous/ethanolic C. racemosa extract BNO 1055 contains 5α-reductase inhibitors.MethodsImmature 24-day-old male rats were fed with testosterone (T)-containing food and injected with 30 mg CR BNO 1055 or 0.5 mg finasteride for 5 days. Average daily T-uptake was 39 mg/animal. Other animals remained untreated or received vehicle injections only.ResultsIn comparison to totally untreated rats the testosterone treatment increased weight of prostates and seminal vesicles 3–5-fold and this proliferation was largely and equipotently inhibited by finasteride and CR BNO 1055. 5α-Dihydrotestosterone concentrations in prostate tissue extracts were also reduced by both compounds and the testosterone-upregulated androgen receptor and insulin like growth factor I gene expression inhibited in the seminals vesicles.ConclusionTaken together, these results indicate that the CR extract BNO 1055 contains one or more potent 5α-reductase inhibitors which may make this extract suitable for the prevention and treatment of prostate cancer and possibly of benign prostate hyperplasia (BPH).

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Ageing
Authors
, , , ,